Animal Models of Lymphangioleiomyomatosis (LAM) and Tuberous Sclerosis Complex (TSC)
- 1 March 2010
- journal article
- research article
- Published by SAGE Publications in Lymphatic Research and Biology
- Vol. 8 (1) , 51-57
Abstract
Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC) are highly desired to enable detailed investigation of the pathogenesis of these diseases. Multiple rats and mice have been generated in which a mutation similar to that occurring in TSC patients is present in an allele of Tsc1 or Tsc2. Unfortunately, these mice do not develop pathologic lesions that match those seen in LAM or TSC. However, these Tsc rodent models have been useful in confirming the two-hit model of tumor development in TSC, and in providing systems in which therapeutic trials (e.g., rapamycin) can be performed. In addition, conditional alleles of both Tsc1 and Tsc2 have provided the opportunity to target loss of these genes to specific tissues and organs, to probe the in vivo function of these genes, and attempt to generate better models. Efforts to generate an authentic LAM model are impeded by a lack of understanding of the cell of origin of this process. However, ongoing studies provide hope that such a model will be generated in the coming years.Keywords
This publication has 39 references indexed in Scilit:
- Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosisMolecular Cancer, 2009
- A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 allelesHuman Molecular Genetics, 2009
- Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin.2003
- TSC2 regulates VEGF through mTOR-dependent and -independent pathwaysCancer Cell, 2003
- Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.2003
- Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors.2002
- Association between a High-Expressing Interferon-γ Allele and a Lower Frequency of Kidney Angiomyolipomas in TSC2 PatientsThe American Journal of Human Genetics, 2002
- A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cellsHuman Molecular Genetics, 2002
- Genetic Identification of a Locus, Mot1, That Affects Renal Tumor Size in the RatGenomics, 2001
- Protective effect of pregnancy for development of uterine leiomyomaCarcinogenesis, 2001